![](https://www.biopharmadive.com/imgproxy/aFO49QT1-ytbqrjsghNN87eKIlQQL6Xv-4smpw2yyUw/g:nowe:909:0/c:6097:3444/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTE0ODM5MjE3OTMuanBn.webp)
AbbVie names new R&D head; Arcutis eczema cream approved
Today, a brief rundown of news from AbbVie and Skyhawk Therapeutics, as well as updates from Arcutis Biotherapeutics and Zevra Therapeutics that you may have missed. AbbVie on Wednesday named Roopal Thakkar as its chief scientific officer and head of …